Current Clinical Trials

UNDER EVALAUATION: VIGILANT: eValuating the efficacy and safety of InitiatinG depemokImab earLy therApy iN COPD with Type 2 inflammation.
  1. Anil Perumbeti, MD
    Anil Perumbeti, MD
  2. Rancho Mirage, CA
  3. Anil Perumbeti, MD
  4. Accepting new patients

Description

Summary

A multi-center, randomized, double-blind, parallel group, placebo-controlled study of the efficacy and safety of early depemokimab initiation as add-on treatment in COPD patients with Type 2 inflammation.

Official Title

VIGILANT: A multi-center, randomized, double-blind, parallel group, placebo-controlled study of the efficacy and safety of early depemokimab initiation as add-on treatment in COPD patients with Type 2 inflammation.

Keywords

COPD

Lead Scientist at Eisenhower Health

Anil Perumbeti, MD
Anil Perumbeti, MD, is Board Certified in  Internal Medicine,Pulmonary Medicine and Critical Care Medicine. Dr. Perumbeti received his medical degree from Northeastern Ohio Medical University, and then completed residency and fellowship programs at the University of Southern California.  Dr. Perumbeti is from a family of physicians which provided a natural pathway to the field of medicine.  He is also a cancer survivor, having been diagnosed and treated at a young age. “H... more
less

Anil Perumbeti, MD, is Board Certified in  Internal Medicine,Pulmonary Medicine and Critical Care Medicine. Dr. Perumbeti received his medical degree from Northeastern Ohio Medical University, and then completed residency and fellowship programs at the University of Southern California. 

Dr. Perumbeti is from a family of physicians which provided a natural pathway to the field of medicine.  He is also a cancer survivor, having been diagnosed and treated at a young age. “Having grown up surrounded by healthcare, I was provided with a positive glimpse into what the field of medicine can be,” states Dr. Perumbeti. “I was drawn to medicine due to my early experience as a sick child and experienced firsthand how a doctor can positively affect someone’s future.”

As medical student, Dr. Perumbeti was initially exposed to the specialty of Pulmonology and Critical Care Medicine, and was immediately drawn to that area of medicine. “I found myself comfortable and challenged,” states Dr. Perumbeti. “This area of medicine mixes the intellect — figuring out why someone is sick, and the practical — helping very sick people get well. I find great satisfaction in treating ill people and guiding them towards healing.”

Knowing his patient’s health goals is a key component to Dr. Perumbeti’s approach to patient care. “I place emphasis on listening and understanding how a patient wants to live and be treated, and what kind of kind of lifestyle they want to achieve.”

Clinical Study Details

  1. Accepting new patients
  2. Interventional
  3. June 17, 2026